Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Inflammation  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Barros SP, Suruki R, Loewy ZG, Beck JD. "A cohort study of the impact of tooth loss and periodontal disease on respiratory events among COPD subjects: modulatory role of systemic biomarkers of inflammation." PLoS One. 2013;8(8):e68592.
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. "Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2009;53(4):596-605.
Beck JD, Pankow J, Tyroler HA, Offenbacher S. "Dental infections and atherosclerosis." Am Heart J. 1999;138(5 Pt 2):S528-33.
D
Duncan BB, Schmidt M I, Chambless LE, Folsom AR, Heiss G. "Inflammation markers predict increased weight gain in smoking quitters." Obes Res. 2003;11(11):1339-44.
Duncan BB, Schmidt M I, Pankow JS, et al. "Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study." Diabetes. 2003;52(7):1799-805.
Duncan BB, Schmidt MI, Chambless LE, Folsom AR, Carpenter M, Heiss G. "Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities." Obes Res. 2000;8(4):279-86.
F
Folsom AR, Desvarieux M, Nieto JF, Boland LL, Ballantyne CM, Chambless LE. "B vitamin status and inflammatory markers." Atherosclerosis. 2003;169(1):169-74.
Folsom AR, Yao L, Alonso A, et al. "Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2015;132(7):578-85.
Folsom AR, Lutsey PL, Heckbert SR, et al. "Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism." J Thromb Haemost. 2018;16(10):1964-1972.
Folsom AR. ""New" risk factors for atherosclerotic diseases." Exp Gerontol. 1999;34(4):483-90.
K
Klein R, Sharrett AR, Klein BE, et al. "Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study." Arterioscler Thromb Vasc Biol. 2000;20(6):1644-50.
Kocarnik JM, Pendergrass SA, Carty CL, et al. "Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study." Circ Cardiovasc Genet. 2014;7(2):178-88.
Kraja AT, Chasman DI, North KE, et al. "Pleiotropic genes for metabolic syndrome and inflammation." Mol Genet Metab. 2014;112(4):317-38.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
P
Pellanda LC, Duncan BB, Vigo A, Rose K, Folsom AR, Erlinger TP. "Low birth weight and markers of inflammation and endothelial activation in adulthood: the ARIC study." Int J Cardiol. 2009;134(3):371-7.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. "Early-life and adult socioeconomic status and inflammatory risk markers in adulthood." Eur J Epidemiol. 2007;22(1):55-66.
Pollitt RA, Kaufman JS, Rose KM, Diez-Roux AV, Zeng D, Heiss G. "Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood." J Epidemiol Community Health. 2008;62(6):484-91.
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. "Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study." Cancer Epidemiol Biomarkers Prev. 2011;20(2):297-307.
R
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
S
Schmidt MI, Duncan BB, Sharrett AR, et al. "Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study." Lancet. 1999;353(9165):1649-52.
Schmidt MI, Duncan BB, Vigo A, et al. "Leptin and incident type 2 diabetes: risk or protection?" Diabetologia. 2006;49(9):2086-96.
W
Walker KA, Hoogeveen RC, Folsom AR, et al. "Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study." Neurology. 2017;89(22):2262-2270.
Walker KA, B Windham G, Brown CH, et al. "The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study." J Alzheimers Dis. 2018;66(3):1041-1052.
Walker KA, Walston J, Gottesman RF, Kucharska-Newton AMaria, Palta P. "Midlife Systemic Inflammation Is Associated With Frailty in Later Life: The ARIC Study." J Gerontol A Biol Sci Med Sci. 2019;74(3):343-349.
Walker KA, Gottesman RF, Wu A, et al. "Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study." Neurology. 2019;92(11):e1256-e1267.
Wong T Y, Klein R, A Sharrett R, et al. "Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons." JAMA. 2002;287(19):2528-33.